AngioDynamics Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study

AngioDynamics (NASDAQ:ANGO) has announced it has enrolled the first patient in its NanoKnife Irreversible Electroporation (IRE) “Data IRE Cancer Treatment”...

uniQure Appoints Matthew Kapusta as Chief Executive Officer

UniQure, a leader in human gene therapy, today announced that its Board of Directors has unanimously approved the appointment of...

AngioDynamics Reports Fiscal 2017 First Quarter Results

AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today...